Loss of IDH2 has been shown to impair oxidative bioenergetics, elevate reactive oxygen species (ROS) production, and promote exaggerated mitochondrial dynamics in prostate cancer cells (Wang et al., 2019). Here, IDH2 is linked to prostate carcinoma.